To assess the incidence of venous thromboembolism (VTE) events by mode of incision among hysterectomies and myomectomies. MATERIALS AND METHODS: This was a retrospective study at Beth Israel Deaconess Medical Center, an academic tertiary-care center. All women who underwent hysterectomy or myomectomy from May 2006 to April 2014 were included. The mode of incision along with other patient and surgical characteristics were reviewed. The incidence of VTE was analyzed by mode of incision and type of surgery. RESULTS: There were 3409 hysterectomies (269 cancer, 3140 benign) and 1006 myomectomies (2 malignancies). The breakdown by mode of incision was: 1761 (54.7%) abdominal hysterectomies (AH), 860 (25.2%) laparoscopic hysterectomies (LH), 312 (9.2%) robotic hysterectomies (RH), 244 (7.2%) laparoscopically assisted vaginal hysterectomies (LAVH), and 232 (6.8%) vaginal hysterectomies (VH); 503 (50%) abdominal myomectomies (AM), 79 (7.9%) laparoscopic myomectomies (LM), 48 (4.8%) robotic myomectomies (RM), and 376 (37.3%) vaginal/hysteroscopic myomectomies (VM). The incidence of VTE was 1.2% for all hysterectomies. Among the different modes of hysterectomy, laparotomies had the highest VTE incidence (AH ¼ 1.9%) followed by LHs (0.6%) and RHs (0.6%). There were no VTEs among LAVHs or VHs. Patients with cancer with AHs had the greatest risk of VTE (3.9%) among all patients. There were no VTEs among cancer patients who underwent a minimally invasive hysterectomy with 0% VTE incidence among LH, RH, LAVH, and VHs. Myomectomies had a very low VTE incidence (0.2%) with only 2 VTEs total. See Table 1 . Two-thirds of all patients received mechanical VTE prophylaxis (e.g. pneumoboots) and 1/3 received pharmacologic prophylaxis (e.g. subcutaneous heparin). Among the VTE patients, the majority received pharmacologic (79.1%) and mechanical (67.4%) prophylaxis. There were more cancers diagnosed among VTE patients (16.3%) compared to the non-VTE patients (6.1%) with a higher VTE incidence among patients with cancer (2.6%) compared to non-cancer patients (0.87%). The median length of surgery was 22 minutes longer for VTE patients compared to non-VTE patients. CONCLUSION: Current CHEST guidelines suggest the same VTE prophylaxis should be applied to major gynecologic surgeries regardless of abdominal versus laparoscopic approach. However, our results suggest the incidence of VTE among hysterectomies and myomectomies differ by mode of incision, with a much lower incidence among minimally invasive modes of surgery.
